跳至主要内容
临床试验/NCT02220556
NCT02220556已完成不适用

Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology

Institut Curie3 个研究点 分布在 1 个国家目标入组 360 人开始时间: 2010年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
360
试验地点
3
主要终点
CTC, CEC or ctDNA incidence

研究概览

简要总结

Fifteen cohorts will be opened. Each cohort will explore one analysis method and/or tumoral type. Up to 50 patient can be included into each cohort.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •18 years old or more
  • •Performance status from 0 to 4
  • •Patient treated followed for histologically confirmed solid tumor type of any of these localization : breast, prostate, uterus, ovary, colon, lung, head and neck, melanoma.
  • •Informed consent form signed.

排除标准

  • •Patient with history of other invasive cancer within 5 years.
  • •Patient treated for any non-invasive cancer
  • •Patient individually deprived of liberty or placed under the authority of a tutor
  • •Geographical condition potentially preventing compliance with the study protocol.

结局指标

主要结局

CTC, CEC or ctDNA incidence

时间窗: 3 years

number of CTC or CEC in 7.5ml of blood

次要结局

  • CTC and CEC molecular characterization(3 years)
  • Circulating tumor DNA (ctDNA) detection and quantification(3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验